INTRODUCTION: Epidemiological studies have shown that moderate alcohol drinkers have a lower death rate for all causes. Alcohol drinking has also been associated with reduced risk of non-Hodgkin lymphoma (NHL). Here, we examined the role of alcohol consumption on NHL survival by type of alcohol consumed and NHL subtype. METHODS: A cohort of 575 female NHL incident cases diagnosed during 1996-2000 in Connecticut was followed-up for a median of 7.75 years. Demographic, clinical, and lifestyle information was collected at diagnosis. Survival analyses were conducted with Kaplan-Meier methods, and hazard ratios (HR) were estimated from Cox Proportional Hazards models. RESULTS: Compared to never drinkers, wine drinkers experienced better overall survival (75% vs. 69% five-year survival rates, p-value for log-rank test = 0.030) and better disease free survival (70% vs. 67% five-year disease-free survival rates, p-value for log-rank test = 0.049). Analysis by NHL subtype shows that the favorable effect of wine consumption was mainly seen for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) (wine drinkers for more than 25 years vs. never drinkers: HR = 0.36, 95% CI 0.14-0.94 for overall survival; HR = 0.38, 95% CI 0.16-0.94 for disease-free survival), and the adverse effect of liquor consumption was also observed among DLBCL patients (liquor drinkers vs. never drinkers: HR=2.49, 95% CI 1.26-4.93 for disease-free survival). CONCLUSIONS: Our results suggest a moderate relationship between pre-diagnostic alcohol consumption and NHL survival, particularly for DLBCL. The results need to be replicated in larger studies. IMPLICATIONS FOR CANCER SURVIVORS: Pre-diagnostic behaviors might impact the prognosis and survival of NHL patients.
INTRODUCTION: Epidemiological studies have shown that moderate alcohol drinkers have a lower death rate for all causes. Alcohol drinking has also been associated with reduced risk of non-Hodgkin lymphoma (NHL). Here, we examined the role of alcohol consumption on NHL survival by type of alcohol consumed and NHL subtype. METHODS: A cohort of 575 female NHL incident cases diagnosed during 1996-2000 in Connecticut was followed-up for a median of 7.75 years. Demographic, clinical, and lifestyle information was collected at diagnosis. Survival analyses were conducted with Kaplan-Meier methods, and hazard ratios (HR) were estimated from Cox Proportional Hazards models. RESULTS: Compared to never drinkers, wine drinkers experienced better overall survival (75% vs. 69% five-year survival rates, p-value for log-rank test = 0.030) and better disease free survival (70% vs. 67% five-year disease-free survival rates, p-value for log-rank test = 0.049). Analysis by NHL subtype shows that the favorable effect of wine consumption was mainly seen for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) (wine drinkers for more than 25 years vs. never drinkers: HR = 0.36, 95% CI 0.14-0.94 for overall survival; HR = 0.38, 95% CI 0.16-0.94 for disease-free survival), and the adverse effect of liquor consumption was also observed among DLBCL patients (liquor drinkers vs. never drinkers: HR=2.49, 95% CI 1.26-4.93 for disease-free survival). CONCLUSIONS: Our results suggest a moderate relationship between pre-diagnostic alcohol consumption and NHL survival, particularly for DLBCL. The results need to be replicated in larger studies. IMPLICATIONS FOR CANCER SURVIVORS: Pre-diagnostic behaviors might impact the prognosis and survival of NHL patients.
Authors: Dixan A Benitez; Eulalia Pozo-Guisado; Alberto Alvarez-Barrientos; Pedro M Fernandez-Salguero; Enrique A Castellón Journal: J Androl Date: 2006-10-18
Authors: W A Ghali; H Quan; R Brant; G van Melle; C M Norris; P D Faris; P D Galbraith; M L Knudtson Journal: JAMA Date: 2001-09-26 Impact factor: 56.272
Authors: Arthur L Klatsky; Yan Li; David Baer; Mary Anne Armstrong; Natalia Udaltsova; Gary D Friedman Journal: Ann Epidemiol Date: 2009-04-25 Impact factor: 3.797
Authors: M G Hertog; D Kromhout; C Aravanis; H Blackburn; R Buzina; F Fidanza; S Giampaoli; A Jansen; A Menotti; S Nedeljkovic Journal: Arch Intern Med Date: 1995-02-27
Authors: Michael K Odutola; Marina T van Leeuwen; Jennifer Turner; Fiona Bruinsma; John F Seymour; Henry M Prince; Samuel T Milliken; Judith Trotman; Emma Verner; Campbell Tiley; Fernando Roncolato; Craig R Underhill; Stephen S Opat; Michael Harvey; Mark Hertzberg; Geza Benke; Graham G Giles; Claire M Vajdic Journal: Cancers (Basel) Date: 2022-05-30 Impact factor: 6.575
Authors: Amanda I Phipps; Qian Shi; Paul J Limburg; Garth D Nelson; Daniel J Sargent; Frank A Sinicrope; Emily Chan; Sharlene Gill; Richard M Goldberg; Morton Kahlenberg; Suresh Nair; Anthony F Shields; Polly A Newcomb; Steven R Alberts Journal: Int J Cancer Date: 2016-05-09 Impact factor: 7.396